Dentaltown May 2024 - 29

(ARTICAINE HCI 4% AND EPINEPHRINE)
SEPTOCAINE
BUY5, GET1
®
BOX OF SEPTOJECT NEEDLES
MANAGING
PAIN FOR
As a world leader in Pain Management, Septodont
offers you quality products and services to help
you provide a more comfortable experience for
your patient.
Septocaine: quality you can trust and the choice
of dentists worldwide with over 150 million
injections per year.
Septocaine®
(articaine HCl and epinephrine) Injection is indicated for local, infiltrative, or conductive anesthesia in both simple and complex
Injection (pain and headache, for example, or convulsions or respiratory
dental procedures. Articaine hydrochloride 4% and epinephrine 1:100,000 is preferred during operative or surgical procedures when improved
visualization of the surgical field is desirable. Reactions to Septocaine®
arrest following accidental intravascular injection) are characteristic of those associated with other amide-type local anesthetics. Septocaine®
Injection contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening
or less severe asthmatic episodes in certain susceptible people. Accidental intravascular injection may be associated with convulsions,
followed by central nervous system or cardiorespiratory depression and coma, progressing ultimately to respiratory arrest. Dental practitioners
and/or clinicians who employ local anesthetic agents should be well versed in diagnosis and management of emergencies that may arise
from their use. Resuscitative equipment, oxygen, and other resuscitative drugs should be available for immediate use. Septocaine®
Injection,
along with other local anesthetics, is capable of producing methemoglobinemia. The clinical signs of methemoglobinemia are cyanosis of the
nail beds and lips, fatigue and weakness. If methemoglobinemia does not respond to administration of oxygen, administration of methylene
blue intravenously 1-2 mg/kg body weight over a 5 minute period is recommended. Hypoesthesia has been reported with use of articaine,
especially in pediatric age groups, which is usually reversible. Prolonged numbness can result in soft tissue injuries such as that of the lips
and tongue in these age groups. Ischemic injury and necrosis have been described following use of articaine with epinephrine and have been
postulated to be due to vascular spasm of terminal arterial branches. Paralysis of ocular muscles has been reported, especially after posterior,
superior alveolar injections of articaine during dental anesthesia. Symptoms include diplopia, mydriasis, ptosis, and difficulty in abduction of
the affected eye. These symptoms have been described as developing immediately after injection of the anesthetic solution and persisting one
minute to several hours, with generally complete recovery.
FREE FACTS, circle 11 on card
YOUR
PRACTICE
Offers valid May 1 through 31, 2024. Not to be combined with any other
offers and are subject to change. Promotional offers are stocked and shipped
with your order by your dealer.
septodontusa.com

http://www.septodontusa.com

Dentaltown May 2024

Table of Contents for the Digital Edition of Dentaltown May 2024